COVID-19 vaccines Vaccine safety data Main navigation COVID-19 vaccines Moderna monovalent Omicron XBB.1.5 COVID-19 vaccine Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccine Pfizer bivalent COVID-19 vaccine Moderna bivalent COVID-19 vaccine Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5-11 years) Moderna COVID-19 vaccine Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine Shingrix® AusVaxSafety is conducting active vaccine safety surveillance of the COVID-19 vaccines in use in Australia to ensure their ongoing safety. The COVID-19 vaccines currently being used are Comirnaty (Pfizer), Vaxzevria (AstraZeneca), Spikevax (Moderna) and Nuvaxovid (Novavax). AusVaxSafety is currently reporting safety data on Pfizer, AstraZeneca, Moderna and Novavax COVID-19 vaccines. Latest monthly COVID-19 vaccine safety data Click on the tiles below to view AusVaxSafety COVID-19 vaccine safety data for specific population groups. Moderna monovalent Omicron XBB.1.5 COVID-19 vaccine View the latest Moderna XBB.1.5 COVID-19 vaccine safety data here Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccine View the latest Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccine safety data here Pfizer bivalent COVID-19 vaccine View the latest Pfizer bivalent COVID-19 vaccine safety data here Moderna bivalent COVID-19 vaccine View the latest Moderna bivalent COVID-19 vaccine safety data here Pfizer COVID-19 vaccine adult formulation View the latest safety data for Pfizer COVID-19 vaccine adult formulation here Pfizer COVID-19 vaccine paediatric formulation (5-11 years) View the latest safety data for Pfizer COVID-19 vaccine paediatric formulation (5-11 years) here Moderna COVID-19 vaccine View the latest Moderna COVID-19 vaccine safety data here Novavax COVID-19 vaccine View the latest Novavax COVID-19 vaccine safety data here AstraZeneca COVID-19 vaccine View the latest AstraZeneca COVID-19 vaccine safety data here Vaccine safety data Main navigation COVID-19 vaccines Moderna monovalent Omicron XBB.1.5 COVID-19 vaccine Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccine Pfizer bivalent COVID-19 vaccine Moderna bivalent COVID-19 vaccine Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5-11 years) Moderna COVID-19 vaccine Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine Shingrix® News & events All news & events 28 November 2023 | News AusVaxSafety monitoring monovalent Omicron XBB.1.5 variant COVID-19 vaccine safety 07 November 2023 | News AusVaxSafety commences enhanced surveillance of Shingrix® following addition to the NIP schedule 19 October 2023 | News AusVaxSafety surveillance of 2023 seasonal flu vaccines concludes with no safety issues identified 14 September 2023 | News Vaxtracker wins Hunter New England Health Excellence Award